REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmasi Limbongan (M) Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Farmasi Limbongan (M) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Farmasi Limbongan (M) Sdn. Bhd. is based in Malaysia. The head office is in Melaka. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on September 12, 2018. Its’ total assets recorded a growth of 16.84%.

Headquarters
No. 7, 9, 11 & 13, Jalan Kristal 1, Taman Limbongan Indah
Melaka; Malacca; Postal Code: 75200

Contact Details: Purchase the Farmasi Limbongan (M) Sdn. Bhd. report to view the information.

Website: http://www.farmasilimbongan.com

Basic Information
Outstanding Shares:
Purchase the Farmasi Limbongan (M) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi Limbongan (M) Sdn. Bhd. report to view the information.
Incorporation Date:
September 12, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Subsidiaries
Caring Chemist Sdn. Bhd.
51%
Smart Health Pharmacy Sdn. Bhd.
51%
Company Performance
Financial values in the chart are available after Farmasi Limbongan (M) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-2.01%
Net Profit (Loss) for the Period
-3.28%
Total assets
16.84%
Total equity
46.05%
Return on Equity (ROE)
-13.91%
Quick Ratio
0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?